Table 2 Comparison of baseline clinical characteristics between the two groups of ALS patients.

From: Analysis of factors influencing sleep disorders in patients with amyotrophic lateral sclerosis

Variables

Total (n = 266)

ALS patients without sleep disorder (n = 90)

ALS patients with sleep disorder (n = 176)

Statistic

P

FSS, mean ± SD

33.36 ± 14.12

27.80 ± 13.72

36.21 ± 13.49

t = − 4.78

 < .001

VAS, mean ± SD

1.95 ± 1.54

1.66 ± 1.30

2.10 ± 1.63

t = − 2.43

0.016

HARS, mean ± SD

11.96 ± 7.86

7.51 ± 4.83

14.24 ± 8.15

t = − 8.43

 < .001

HDRS, mean ± SD

11.83 ± 7.27

8.91 ± 4.67

13.33 ± 7.89

t = − 5.72

 < .001

ESS, mean ± SD

3.22 ± 1.73

3.07 ± 1.73

3.30 ± 1.73

t = − 1.05

0.297

ALSFRS-RB, mean ± SD

10.06 ± 2.39

10.46 ± 2.25

9.85 ± 2.45

t = 1.96

0.052

ALSFRS-RL, mean ± SD

14.74 ± 5.88

16.02 ± 5.34

14.09 ± 6.04

t = 2.57

0.011

ALSFRS-RR, mean ± SD

10.86 ± 2.11

11.43 ± 1.51

10.57 ± 2.31

t = 3.64

 < .001

ALSFRS-R, mean ± SD

35.66 ± 8.50

37.91 ± 7.26

34.51 ± 8.87

t = 3.35

 < .001

Disease progression rate, Mean ± SD

1.71 ± 1.83

1.34 ± 1.27

1.90 ± 2.03

t = − 2.40

0.017

Disease duration, mean ± SD

17.44 ± 8.34

17.58 ± 7.92

17.37 ± 8.57

t = 0.20

0.842

FVC, M (Q₁, Q₃)

76.76 (63.80, 90.50)

74.81 (62.31, 89.70)

79.08 (69.56, 92.31)

Z = − 1.64

0.100

Age at onset, M (Q₁, Q₃)

52.36 (44.99, 59.01)

48.57 (42.48, 56.27)

53.54 (47.06, 59.42)

Z = − 2.91

0.004

Site of onset, n(%)

   

χ2 = 0.00

0.963

 Bulbar

41 (15.41)

14 (15.56)

27 (15.34)

  

 Limb

225 (84.59)

76 (84.44)

149 (84.66)

  

EI escorial classification n(%)

   

0.102

 1

4 (1.50)

2 (2.22)

2 (1.14)

  

 2

31 (11.65)

15 (16.67)

16 (9.09)

  

 3

231 (86.84)

73 (81.11)

158 (89.77)

  
  1. t: t-test, Z: Mann–Whitney test, χ2: Chi-square test, –: Fisher exact. SD: standard deviation, M: Median, Q₁: 1st Quartile, Q₃: 3st Quartile.
  2. FSS,Fatigue Severity Scale; VAS,Visual Analog Scale; HARS, Hamilton Anxiety Rating Scale; HDRS, Hamilton Depression Rating Scale; ESS,Epworth Sleepiness Scale;ALSFRS-RB,Amyotrophic Lateral Sclerosis Functional Rating Scale-revised Bulbar Function;ALSFRS-RL, Amyotrophic Lateral Sclerosis Functional Rating Scale-revised limbs; ALSFRS-RR,Amyotrophic Lateral Sclerosis Functional Rating Scale-revised Respiratory Function; ALSFRS-R, Amyotrophic Lateral Sclerosis Functional Rating Scale-revised;FVC,Forced Lung Function; The Student’s t-test (with Mann–Whitney U test when necessary) was used to compare continuous variables and the chi-squared test was used to analyze categorical variables. The meaning of the bold values represented statistically significant values in the statistical analysis.The meaning of the bold values represented statistically significant values in the statistical analysis.